Peptide nucleic acid (PNA) is one of the most useful DNA analogs in a wide variety of gene analysis in human cells. In order to exhibit its maximal functions, PNA must be localized to a desired place (e.g., nucleus, cytoplasm and other organelles). Here, we introduced PNAs into HeLa cells by electroporation and examined their localization at various time points. The PNA which binds to the mitochondrial COII gene was initially accumulated in the nucleus, and thereafter mostly transferred to cytoplasm. This time-dependent intracellular localization of PNA is ascribed to the breakdown of the nuclear envelope in the cell division. On the other hand, another PNA that binds to telomere repeat sequence mostly remained in the nucleus, even after the cell division occurred. The retention of this PNA in the nucleus was further enhanced when it was conjugated with Cy3.
Peptide nucleic acid (PNA), elegantly developed by Nielsen et al. [1] , has been widely used in gene analysis, because of its strong binding affinity to DNA and RNA [2, 3] . For instance, antisense PNA binds to mRNA in cells and represses its translation [4, 5] . Alternatively, PNA either alters the splicing pattern [6, 7] or causes exon skipping [8] by hybridizing to premature mRNA. The transcription is also inhibited by the antigene effect of sense PNA [9] . PNA is also useful to visualize the localization of the target sequence in living cells [10] . In addition, we and another group have recently indicated the possibility of gene targeting by PNA in human cells [11] [12] [13] . The key issue in such applications is how to introduce PNA efficiently into cells and selectively localize it at a desired place in them (e.g., nucleus, cytoplasm and other organelles).
According to previous studies, intracellular localization of PNA strongly depends on the transfection methods, the chemical modifications of PNA, and also on cell lines. For example, in the free uptake method in which PNA is added to the medium and incubated with cells, PNA bearing a long Lys tail is primarily located in cytoplasm in HeLa cells [14] . When PNA was conjugated with a nuclear localization signal peptide, it was localized in the nucleus of neuroblastoma cells [15] . Phosphonate-bearing PNA, introduced to HeLa cells by lipofection, existed in both nucleus and cytoplasm [7] . On the other hand, unmodified PNAs cannot be introduced to cells by using either cationic lipids or polymers, since they are neutral in charge and cannot bind to these reagents (only negatively charged DNA and RNA are amenable to this method). In this study, we introduce PNAs into HeLa cells by an electroporation method, which should be applicable to a variety of PNA analogs and versatile cells. The localization of PNAs in the cells is analyzed at various time points after the electroporation. Crucial roles of the cell division processes in the PNA localization, as well as of PNA sequences and their modification, are shown.
In this study, we used three PNAs (PNA1, PNA2, and PNA3, shown in Figure 1 ). PNA1 is complementary to part of the mitochondrial COII gene sequences encoded in nuclear genomic DNA (nuclear mitochondrial DNA; Numt) [16] . This PNA may also target the mitochondrial COII gene on mitochondrial DNA, if the PNA is localized in mitochondria. In order to increase the water solubility, one and two Lys residue(s) were attached to both its N and C termini, respectively. To this PNA, a biotin was also conjugated so that it can be detected by using fluorescent streptavidin (Alexa488-conjugated streptavidin). PNA2 is complementary to human telomere sequence ([GGGATT]n repeats), and modified with a biotin and three Lys residues in exactly the same manner as PNA1. PNA3 has the same sequence as PNA2, but bears Cy3, with a 8-amino-3,6-dioxa-octanoic acid linker, in order to detect its intracellular localization by fluorescence microscopy without fixation and staining.
First, Hela cells were mixed with PNA1 (bearing a biotin), electroporated, washed, and cultured for several hours to adhere to the bottom of the chamber slide. Then, the cells were fixed with 4% paraformaldehyde, and the PNA1 was detected by Alexa488conjugated streptavidin. The cell nucleus was simultaneously stained with DAPI. As shown in the fluorescent microscopy images in Figure 2 , almost all the HeLa cells emitted green fluorescence from Alexa488 (the middle image). Apparently, the PNA1 was efficiently introduced into the HeLa cells by the present electroporation method (the detailed conditions are presented in the Experimental section).
Next, we analyzed the localization of PNA1 at various time points (5, 23, and 47 h) after the electroporation. The PNA1 and nucleus were stained with Alexa488 and DAPI, respectively. At 5 h after the electroporation, the green fluorescence from Alexa488 was observed throughout the whole cells ( Figure 3 , the upper panels). The fluorescence in the nuclear region was especially strong, showing that PNA1 was first accumulated in the nucleus when it was incorporated by electroporation. However, the green fluorescence in the nucleus gradually weakened, and at 23 h after electroporation the nucleus was less fluorescent than the cytoplasm (the lower panels in Figure 3 ). The images of the cells after 47 h incubation were almost the same as those at 23 h incubation (data not shown). It is concluded that the PNA1 is localized in the nucleus in the early stage after electroporation, but thereafter exported from the nucleus to the cytoplasm. The doubling time of Hela cells is about 22 h [17] . Accordingly, the cells should have undergone at least one cell division when they were analyzed at 23 h after the electroporation. It is possible that the observed shift of PNA1 from the nucleus to the cytoplasm could reflect this cell division. In order to shed light on this subject, we incubated the cells overnight (around 18 h) after the electroporation and analyzed the localization of PNA1 (note that this incubation time is shorter than the doubling time of the cells). Interestingly and importantly, three different patterns of the cellular localization of PNA1 were observed, as shown in Figure 4 . In the single cells, which have not yet divided, PNA1 was primarily localized in the nucleus (Figure 4a ). In the twin cells that were supposedly formed just after the cell division, however, there existed few PNA1 in the nucleus and most were perceived in the cytoplasm (Figure 4b ). In the double nucleated cell that may be in the course of cell division, PNA1 was observed in both the nucleus and cytoplasm (Figure 4c) . Apparently, the PNA localization varies with the cell cycle progression after the electroporation.
The target COII gene sequence of PNA1 also exists in mitochondria. Thus, PNA1 introduced into HeLa cells may also target this site, in addition to the site in nuclear genomic DNA, if it is transferred to mitochondria. In order to examine this possibility, the mitochondria in the cells were stained with MitoTracker. However, the PNA1 was hardly co-localized with the mitochondria (data not shown). This result indicates that this PNA cannot penetrate the mitochondrial membrane to enter this organelle under the electroporation conditions. Cellular localization of transfected PNAs may depend on their sequences. Therefore, we also analyzed the localization of PNA2, which binds to human telomere repeat sequence. Note that PNA2 has the same modifications as PNA1 (a biotin in the C-terminus, as well as one and two Lys residue(s) in its N and C termini) so that their cellular localizations can be directly compared. As shown in the upper panels of Figure 5A , at 4 h incubation after the electroporation, strong fluorescence was observed at the nucleus although the whole cells were weakly fluorescent. At 18 and 27 h incubation after the electroporation, strongly fluorescent spots were observed in the nucleus, reflecting the localization of the PNA to telomere regions. These spots were observed even in the double nucleated cell (Figure 5B-a) and twin cells that may be either during or just after cell division ( Figure 5B-b ). This result is in contrast with the time-dependent shift of PNA1 described above. The dominant nuclear localization of PNA2, even after the cell division, is probably associated with strong binding of this PNA to the single-stranded overhang portion at the end of telomere DNA. Even when the cells are divided, this PNA strongly sticks to the DNA and remains in the nucleus.
PNA3 has the same sequence as PNA2, but conjugated with Cy3 in place of a biotin and three Lys residues. In most of the cells, the whole nucleus emitted red fluorescence and no strong emission spots were observed (the lower panels of Figure 5A ).Thus the cellular localization of PNA3 was different from that of PNA2. Essentially the same results were obtained when a lower concentration of PNA3 (5 M) was used for electroporation (data not shown). The red fluorescence from the Cy3 of PNA3 was observed in the whole nucleus, even after 48 h. Under the same conditions, however, the PNA2 almost completely disappeared from the nuclei (compare the upper and the lower panels of Figure 5A ). Nuclear retention of PNA3 is notably promoted by the Cy3 modification.
In this study, we showed that PNA, irrespective of its sequence, is localized in the nucleus of HeLa cells in the early stage after the electroporation. In the later stage involving cell division processes, however, the intracellular localization of the PNA strongly depends on the sequence of PNA. PNA1, which is complementary with a part of the mitochondrial COII gene, exists during the cell division in both the nucleus and the cytoplasm. Once the cell division is completed, however, this PNA is localized mainly in the cytoplasm. Along with the breakdown of the nuclear envelope in M phase, the PNA diffuses from the nucleus into the cytoplasm. Even after the nuclear envelope is reformed in the following cell cycle, the PNA does not return to the nucleus. These results indicate that precise control of the cell cycle is crucially important to introduce PNA efficiently into a desired place in the cells. This factor can strengthen the antisense, antigene or other effects of PNA.
Experimental
Cell line and culture: HeLa cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 50 units/mL penicillin, and 50 μg/mL streptomycin. The cultures were incubated in a humidified atmosphere at 37°C and 5% CO 2 .
Cell transfection:
Electroporation experiments were performed using a Neon TM Transfection System (Invitrogen). A total of 5.0×10 4 cells in 10 L of R buffer were mixed with PNAs (14 M in the case of PNA1 and PNA2, 5 or 10 M in the case of PNA3) and electroporated under the optimized conditions (Square wave, Pulse Voltage 1005 V, Pulse Width 35 ms, Pulse Number 2). After electroporation, the cells were placed in the medium without antibiotics.
PNA synthesis: PNA1 and PNA2 were synthesized according to the published methods [18] . For biotinylation of this PNA, the PEG linker monomer bearing a biotin (Fmoc-Glu(biotinyl-PEG)-OH from Novabiochem) was used. The PNA strands were purified by reversed-phase HPLC and characterized by MALDI-TOFMS (Bruker, AutoFLEX). PNA3 was purchased from FASMAC Co., Ltd.
Fluorescence microscopy:
Transfected HeLa cells were transferred to an 8-well chamber (BD) and cultured in normal medium for 5 h, 23 h, or 47 h. The cells were fixed with 4% paraformaldehyde in PBS for 20 min. The fixed cells were permeabilized with 0.2% Triton X-100 in PBST for 2 min and blocked with 3% skim milk in PBST for 20 min. These cells were incubated with 1 µg/mL Alexa Fluor 488 conjugated with streptavidin (Molecular Probes) for 40 min. Finally, the cells were incubated for 5 min with 300 nM DAPI in PBS. All the processes of the staining were performed at room temperature.
The stained cells were analyzed with a DMI6000B (Leica Microsystems) with a ×20 N PLAN L objective [numerical aperture (NA), 0.35], and a ×40 PL APO CS oil immersion objective [NA, 1.25]. The Alexa 488 conjugated streptavidin was detected using a 480/40 excitation, 527/30 emission filter set. The Cy3-conjugated PNA was analyzed using a 546/12 excitation, 600/40 emission filter set.
